Arrang J M, Garbarg M, Lancelot J C, Lecomte J M, Pollard H, Robba M, Schunack W, Schwartz J C
Nature. 1987;327(6118):117-23. doi: 10.1038/327117a0.
New drugs selective for histamine H3-receptors can be used to establish that these receptors are involved in the feedback control of histamine synthesis and release, and to demonstrate their distribution in the brain and peripheral tissues. These drugs provide new tools for affecting physiological and possibly pathological conditions in which histamine is involved.
对组胺H3受体具有选择性的新药可用于证实这些受体参与组胺合成和释放的反馈控制,并证明它们在脑和外周组织中的分布。这些药物为影响涉及组胺的生理和可能的病理状况提供了新工具。